News
Health Canada approves Ozempic(R) to reduce the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular death in adults with type 2 diabetes and chronic kidney disease
Ozempic(R) is the first-and-only medication indicated for both the once-weekly treatment of adult patients with type 2 diabetes mellitus to improve glycemic control and to reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline,
With Halloween shops opening and pumpkin spice in the air, it’s also time to think about getting a new COVID-19 vaccine for ...
Two months after announcing most Albertans would need to pay for COVID-19 vaccines if they want one this season, the province now says it will cover the cost for health-care workers.
Canada has approved a first-of-its-kind drug for multiple myeloma, a significant advancement in the treatment of a cancer that has no cure.
Apotex Inc. ("Apotex" or the "Company"), the Canadian-based global health company, today announced that Health Canada has approved Aflivu™ (aflibercept), a biosimilar to Eylea®, indicated for ...
Health officials are warning Canadians to steer clear of certain pistachio products, including the popular Dubai pistachio and knafeh milk chocolate, after a salmonella outbreak has affected more than ...
The joint recall includes Health Canada, the United States Consumer Product Safety Commission and i-Drink Products Inc.
Asianet Newsable on MSN1d
Iovance Stock Rises 4% On Health Canada Approval For Cancer Immunotherapy: Retail Thinks ‘Patience Will Pay Off’
The approval from Health Canada is conditional, pending results of trials to confirm the immunotherapy’s clinical benefit.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback